Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Dec-2025 | 425.95 | 426 | 419.05 | 424.75 | 3,266 | 4,64,66,084.9 | 50,944 |
02-Dec-2025 | 428 | 428 | 419.1 | 425.3 | 5,503 | 7,63,04,417.9 | 1,09,885 |
03-Dec-2025 | 430 | 430 | 418.2 | 420.85 | 3,710 | 4,37,24,234.3 | 59,622 |
04-Dec-2025 | 424.05 | 424.05 | 418.85 | 420.3 | 2,971 | 3,24,90,442.85 | 43,977 |
05-Dec-2025 | 420 | 424.9 | 418.05 | 420 | 6,978 | 3,32,36,116.5 | 48,446 |
08-Dec-2025 | 415.5 | 422.75 | 414 | 418.35 | 7,481 | 13,00,43,009.75 | 2,21,523 |
09-Dec-2025 | 416 | 423.25 | 415.05 | 421.6 | 4,183 | 4,30,64,947.05 | 56,886 |
10-Dec-2025 | 418 | 428.5 | 418 | 425.95 | 4,594 | 5,76,93,234.35 | 67,058 |
11-Dec-2025 | 422 | 432 | 420.9 | 430.45 | 3,588 | 2,56,70,120.35 | 33,414 |
12-Dec-2025 | 430.6 | 432.45 | 419.95 | 423.05 | 5,876 | 7,07,46,511.25 | 88,493 |
15-Dec-2025 | 425.95 | 425.95 | 420.45 | 423.05 | 1,798 | 1,44,85,764.15 | 18,639 |
16-Dec-2025 | 422.1 | 424.85 | 420.5 | 420.7 | 4,898 | 1,78,12,736.8 | 26,561 |
17-Dec-2025 | 420.75 | 422.45 | 417.55 | 420.6 | 2,000 | 2,33,46,928.85 | 32,386 |
18-Dec-2025 | 419.05 | 427.05 | 417.5 | 422.05 | 3,404 | 4,90,50,991.3 | 73,890 |
19-Dec-2025 | 422.1 | 431 | 422 | 427.2 | 3,334 | 3,37,51,723.55 | 30,375 |
22-Dec-2025 | 435 | 446.95 | 431.55 | 443.15 | 10,824 | 13,69,67,419.6 | 89,050 |
23-Dec-2025 | 458 | 480.5 | 446.1 | 452.15 | 70,569 | 1,84,57,51,766.15 | 5,41,034 |
24-Dec-2025 | 447.1 | 453.2 | 444.95 | 446.3 | 5,955 | 8,02,56,703 | 78,107 |
26-Dec-2025 | 449.9 | 450 | 442.05 | 446.4 | 4,054 | 5,12,64,116.05 | 51,985 |
29-Dec-2025 | 450 | 450.3 | 444.05 | 447.15 | 3,984 | 6,00,09,295.4 | 58,653 |
30-Dec-2025 | 449.75 | 453 | 442.85 | 450.85 | 5,391 | 6,79,65,547.25 | 69,951 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
